scholarly journals METABOLIC BONE DISEASE AND REVERSIBLE RENAL TUBULAR DYSFUNCTION IN A CHRONIC ALCOHOLIC

2000 ◽  
Vol 56 (1) ◽  
pp. 64-66
Author(s):  
MK GARG ◽  
N TANDON
2014 ◽  
Vol 24 (3) ◽  
pp. 171 ◽  
Author(s):  
M Vadivelan ◽  
S Giridharan ◽  
N Balamurugan ◽  
D. K. S. Subrahmanyam

2011 ◽  
Vol 2011 (aug11 1) ◽  
pp. bcr0420114121-bcr0420114121 ◽  
Author(s):  
A. V. Palkar ◽  
M. S. Shrivastava ◽  
N. J. Padwal ◽  
R. N. Padhiyar ◽  
N. Moulick

2020 ◽  
Vol 13 (6) ◽  
pp. e234929
Author(s):  
Gitanjali Jain ◽  
Suprita Kalra ◽  
Gautam Vasnik ◽  
Sumit Bhandari

Sjogren’s syndrome (SS) is a chronic, autoimmune, inflammatory disorder affecting primarily the salivary and lacrimal glands with potential for systemic involvement. The disease predominantly occurs in women in the age group of 35–45 years and is relatively rare in children. It mainly affects salivary and lacrimal glands with potential for systemic involvement. Children presenting with the severe metabolic bone disease at the very outset has not been reported in the paediatric literature. We report a 13-year-old girl who presented with pain in multiple large joints with predominant involvement of hip joints leading to difficulty in walking for the past 6 months and unintentional weight loss of the same duration. Investigations revealed distal renal tubular acidosis with severe metabolic bone disease as an extra-glandular manifestation of primary SS.


2020 ◽  
Vol 21 (1) ◽  
Author(s):  
WMSN Gunaratne ◽  
DMDIB Dissanayake ◽  
KADS Jayaratne ◽  
NP Premawardhana ◽  
Sisira Siribaddana

2021 ◽  
Vol 14 (1) ◽  
pp. e237987
Author(s):  
Hiya Boro ◽  
Alpesh Goyal ◽  
Shailendra Singh Naik ◽  
Nikhil Tandon

Primary Sjögren’s syndrome (pSS) is a chronic slowly progressive autoimmune disease characterised by lymphocytic infiltration of salivary and lacrimal glands with varying degree of systemic involvement. Renal involvement, a recognised extraglandular manifestation of pSS, is commonly related to tubular dysfunction and generally manifests as distal renal tubular acidosis (RTA), proximal RTA, tubular proteinuria and nephrogenic diabetes insipidus. Untreated long-standing RTA is known to cause metabolic bone disease. Here, we present the report of a patient with sclerotic metabolic bone disease related to pSS with combined distal and proximal RTA and negative workup for other causes of sclerotic bone disease. A significant clinical and biochemical improvement, including recovery of proximal tubular dysfunction, was noted with alkali therapy. This case suggests the need to consider pSS in the diagnostic algorithm of a patient presenting with sclerotic bone disease.


2021 ◽  
Vol 1 (1) ◽  
pp. 59
Author(s):  
Hiya Boro ◽  
Saurav Khatiwada ◽  
Sarah Alam ◽  
Suraj Kubihal ◽  
Vinay Dogra ◽  
...  


2021 ◽  
Vol 1 (1) ◽  
pp. 59
Author(s):  
Hiya Boro ◽  
Saurav Khatiwada ◽  
Sarah Alam ◽  
Suraj Kubihal ◽  
Vinay Dogra ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document